Abstract
Transcatheter arterial chemoembolization (TACE) is one of the most commonly performed procedures in interventional radiology and is currently used for the palliative treatment of primary and metastatic hepatic malignancies. A new type of TACE is TACE with drug-eluting microspheres, which is currently gaining wide acceptance worldwide. In this article, we will review some technical components, patient selection, current results, and future directions of TACE and TACE with drug-eluting microspheres for primary and metastatic liver cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 156-162 |
| Number of pages | 7 |
| Journal | Cancer Journal |
| Volume | 16 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2010 |
Fingerprint
Keywords
- Drug-eluting microspheres
- Hepatic metastases
- Hepatocellular carcinoma
- Transcatheter arterial chemoembolization
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Chemoembolization for primary and metastatic liver cancer. / Liapi, Eleni A; Geschwind, Jean Francois H.
In: Cancer Journal, Vol. 16, No. 2, 03.2010, p. 156-162.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Chemoembolization for primary and metastatic liver cancer
AU - Liapi, Eleni A
AU - Geschwind, Jean Francois H
PY - 2010/3
Y1 - 2010/3
N2 - Transcatheter arterial chemoembolization (TACE) is one of the most commonly performed procedures in interventional radiology and is currently used for the palliative treatment of primary and metastatic hepatic malignancies. A new type of TACE is TACE with drug-eluting microspheres, which is currently gaining wide acceptance worldwide. In this article, we will review some technical components, patient selection, current results, and future directions of TACE and TACE with drug-eluting microspheres for primary and metastatic liver cancer.
AB - Transcatheter arterial chemoembolization (TACE) is one of the most commonly performed procedures in interventional radiology and is currently used for the palliative treatment of primary and metastatic hepatic malignancies. A new type of TACE is TACE with drug-eluting microspheres, which is currently gaining wide acceptance worldwide. In this article, we will review some technical components, patient selection, current results, and future directions of TACE and TACE with drug-eluting microspheres for primary and metastatic liver cancer.
KW - Drug-eluting microspheres
KW - Hepatic metastases
KW - Hepatocellular carcinoma
KW - Transcatheter arterial chemoembolization
UR - http://www.scopus.com/inward/record.url?scp=77951462245&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951462245&partnerID=8YFLogxK
U2 - 10.1097/PPO.0b013e3181d7e905
DO - 10.1097/PPO.0b013e3181d7e905
M3 - Article
C2 - 20404613
AN - SCOPUS:77951462245
VL - 16
SP - 156
EP - 162
JO - Cancer journal (Sudbury, Mass.)
JF - Cancer journal (Sudbury, Mass.)
SN - 0765-7846
IS - 2
ER -